Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹163 Cr₹170 Cr₹84 Cr₹88 Cr₹74 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of GLAND PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of GLAND PHARMA is ₹163 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹163 Cr
Mar2024₹170 Cr
Mar2023₹84 Cr
Mar2022₹88 Cr
Mar2021₹74 Cr

How is Deferred Tax Assets / Liabilities of GLAND PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹163 Cr
-4.09
Mar2024 ₹170 Cr
101.52
Mar2023 ₹84 Cr
-4.05
Mar2022 ₹88 Cr
18.79
Mar2021 ₹74 Cr -

Compare Deferred Tax Assets / Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹28,372.8 Cr -3.4% 1.4% -0.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹392,147.0 Cr -5.2% -7.6% -8.6% Stock Analytics
DIVIS LABORATORIES ₹161,208.0 Cr -5.6% -7.3% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,190.0 Cr -0.6% 4.8% 25% Stock Analytics
CIPLA ₹110,790.0 Cr -4.5% -9.7% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,587.0 Cr -2.6% -9.7% -10.5% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-3.4%

1.4%

-0.6%

SENSEX

-1.3%

-3.1%

6.8%


You may also like the below Video Courses